Wim Vandenberghe

23PUBLICATIONS
105CO-AUTHORS
Photonics, optoelectronics and optical communicationsEpigenetics (incl. genome methylation and epigenomics)Peripheral nervous systemNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 22, 2026
Initial Experience with Pseudomonopolar Local Field Potentials in Deep Brain Stimulation for Parkinson's Disease.

|Apr 10, 2026
Anatomy-corrected metabolic asymmetry predicts seizure freedom after surgery in focal cortical dysplasia.

Jeroen Gijs, Evy Cleeren, Jaiver Macea

|Mar 06, 2026
Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial.

Günter Höglinger, Wim Vandenberghe, Dirk Woitalla

|Dec 24, 2025
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.

Christian A Ganoza, Ana Westenberger, Jefri J Paul

|Oct 30, 2025
VPS35 mutation inhibits PINK1/parkin-mediated mitophagy via increased LRRK2 kinase activity.

Liselot Manders, Thibaut Heyninck, Dorien Imberechts

|Oct 10, 2025
PEX14 acts as a molecular link between optineurin and the autophagic machinery to induce pexophagy.

Hongli Li, Suyuan Chen, Celien Lismont

Pageof 4

Frequent Collaborators

5 joint publications

Aline Delva

4 joint publications

Koen Van Laere

3 joint publications

Dorien Imberechts

3 joint publications

Alice Nieuwboer